Measles Hits 35-Year High in the US: Why This Vaccine-Preventable Disease Threatens Kidney Stone Patients

July 28, 2026 — The Centers for Disease Control and Prevention reported this week that US measles cases have reached 2,318 for the year, surpassing the previous record of 2,289 set in 2025 and reaching a 35-year peak. The hospitalization rate stands at 7%, with 10% of hospitalized patients being children under 5 years old. The overwhelming majority of cases — over 90% — occurred in unvaccinated individuals or those with unknown vaccination status. For kidney stone patients, a measles outbreak is not just a public health story — it is a personal dehydration risk story with direct urological consequences.

Measles → Fever → Dehydration → Kidney Stones: The Pathway

Any febrile illness — measles, influenza, COVID-19, bacterial pneumonia, or even a severe common cold — increases kidney stone risk through a well-characterized pathway:

1. Fever-driven insensible water loss. Measles fevers routinely reach 103-105°F (39.4-40.6°C). Each degree Celsius above normal body temperature increases insensible water loss through the skin and respiratory tract by approximately 10%. At 40°C, a patient loses roughly 1.5-2.0 liters of water per day through the fever mechanism alone — before accounting for any losses from sweating, the characteristic measles cough and coryza (runny nose), or vomiting and diarrhea, which occur in a significant minority of cases.
2. Reduced oral intake during acute illness. Measles patients experience severe malaise, photophobia (light sensitivity), sore throat, and often nausea — all of which suppress the desire to drink. A patient who normally consumes 2-3 liters of fluid per day may consume less than 500 mL during the 3-5 day acute phase of measles. Combined with fever-driven losses, the net fluid deficit can reach 4-6 liters over 48-72 hours — sufficient to reduce urine output to oliguric levels, concentrating urine to the point where calcium oxalate supersaturation and spontaneous crystal nucleation become thermodynamically favorable.
3. Inflammatory cytokine cascade. Measles infection triggers robust release of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which damage renal tubular epithelial cells. Damaged tubular cells expose phospholipid surfaces that serve as nucleation sites — templates upon which calcium oxalate crystals preferentially adhere and aggregate. This "inflammatory nidus" mechanism was documented in a comprehensive 2025 Nature Reviews Nephrology review and applies to any infection causing significant systemic inflammation.

Why 2,318 Cases Matters for Stone Formers — Even for the Vaccinated

The 7% hospitalization rate among measles patients translates to approximately 162 hospitalizations from this outbreak alone. For kidney stone patients who contract measles — regardless of their vaccination status (breakthrough infections in vaccinated individuals do occur, though they are typically milder) — the dehydration risk is real and significant. Even a milder case with a fever of only 101-102°F can produce enough insensible water loss to dangerously concentrate urine in a patient with a history of calcium oxalate stones.

For parents of children with a history of kidney stones (juvenile nephrolithiasis is rare but does occur), the current outbreak is an urgent reason to confirm vaccination status. The MMR (measles, mumps, rubella) vaccine is 97% effective after two doses. A single case of measles in an unvaccinated stone-forming child creates a compound risk — the infection itself plus the stone risk from dehydration.

5 Protections for Stone Formers During Infectious Disease Season

1. Confirm vaccination status. This is not a kidney stone recommendation — it is an infectious disease prevention recommendation. But because febrile illness drives stone formation, vaccination is indirectly kidney stone prevention. The MMR vaccine is safe, effective, and widely available. Two doses provide 97% protection. Most adults born before 1957 are considered immune due to natural exposure; most born after 1989 received two doses as children. If you are uncertain of your status, a simple blood test (measles IgG titer) can confirm immunity. Check with your primary care provider.
2. Have a "sick day" hydration plan ready. Discuss with your urologist a written protocol for what to do if you develop a febrile illness and cannot maintain oral fluid intake. This protocol should specify: (a) your baseline daily fluid target (typically 2.5-3.0 liters); (b) the threshold for seeking medical attention (typically "if unable to keep down any fluids for more than 12 hours"); (c) whether you should keep a prescription antiemetic (anti-nausea medication) at home to maintain oral hydration during illness. Do not wait until you are sick to figure out what to do.
3. Stock oral rehydration salts (ORS). The WHO-formulated ORS packet ($0.50, available at any pharmacy without a prescription) contains a precisely calibrated mixture of glucose, sodium, potassium, and citrate. The glucose facilitates sodium and water absorption in the small intestine via the SGLT1 co-transporter — making ORS approximately 2-3 times more effective than plain water for rehydration during febrile illness. Keep 10 packets at home. If you cannot find commercial ORS, an emergency substitute is: 1 liter clean water + 6 level teaspoons of sugar + 0.5 level teaspoon of salt.
4. Monitor urine color during illness. The single most important clinical sign during any febrile illness for a stone former is urine color. Dark yellow or amber urine (specific gravity >1.020) during illness indicates concentrated urine that is thermodynamically favorable for crystal formation. Pale yellow urine (specific gravity 1.005-1.015) indicates adequate hydration. Check at each void. If urine darkens and you cannot increase oral intake, seek medical attention for IV fluids before the stone forms — prevention is vastly less expensive and less painful than emergency treatment.
5. NSAID caution during febrile illness. Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, aspirin) are commonly used for fever reduction but reduce renal blood flow and glomerular filtration rate — exactly when the kidneys are already stressed by dehydration and inflammation. For fever management during illness, acetaminophen (paracetamol) is preferred from a renal perspective. This is not a blanket prohibition against NSAIDs — they have their place in stone pain management — but during febrile illness with dehydration risk, acetaminophen is the safer antipyretic choice.

The Broader Lesson

Measles is a specific, dramatic example of a general principle: any significant illness that causes fever and fluid loss increases kidney stone risk. Influenza, COVID-19, bacterial pneumonia, pyelonephritis (kidney infection), and gastroenteritis all operate through the same dehydration pathway. The 2,318 measles cases in 2026 will cause some number of kidney stone events — not because measles directly causes stones, but because the dehydration that accompanies it creates the chemical conditions for stone formation in susceptible individuals.

Check your vaccination status. Stock ORS at home. Know your sick-day hydration protocol. Look up hydration-friendly foods on OxalateWatch to identify high-water-content, low-oxalate options. The stone you prevent by being prepared is worth infinitely more than the stone you treat in the emergency department.

Source: CDC measles surveillance data (July 2026); Harvard T.H. Chan SPH (2024) oxalate data; Nature Reviews Nephrology (2025) inflammatory crystal nucleation review; WHO ORS formulation monograph; MMWR measles vaccination effectiveness data.